This study investigates the use of central-boost ablative radiation therapy (CBART) for large solid tumors. The purpose of this study is to explore how this technique can provide high radiation doses to tumors without increasing the risk of severe side effects.
The study evaluates the safety and effectiveness of CBART in treating large tumors or those near sensitive organs. It assesses whether this method can improve treatment outcomes while minimizing risks.
- Who can participate: Adults aged 18 to 75 with confirmed lung, liver, pancreas, or retroperitoneal tumors may participate. Key factors include tumor size, proximity to organs at risk, ECOG status, and specific blood test results.
- Study details: Participants will receive central-boost ablative radiation therapy, which involves delivering high radiation doses to specific tumor areas.
How understandable was the trial content above?
Hard to understand
Easy to understand